Skip to main content
Clinical Trials/NCT04792177
NCT04792177
Completed
Not Applicable

SHER 2: Internet-delivered Emotion Regulation Skills Training for Sexual Health: a Randomized Controlled Trial

University of Luxembourg1 site in 1 country62 target enrollmentMay 5, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sexual Dysfunction
Sponsor
University of Luxembourg
Enrollment
62
Locations
1
Primary Endpoint
Change in Female Sexual Function Index (FSFI) at 6 months
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Introduction: Emotion regulation difficulties have been associated with mental disorders and sexual dysfunctions. Traditional face-to-face transdiagnostic emotion regulation interventions have shown positive results for emotional and personality disorders. Only recently have the effects of these interventions on sexual health started to be investigated. Internet-delivered psychological interventions have several advantages over face-to-face interventions, such as cost-effectiveness, accessibility and suitability for people who experience shame because of their stigmatized problematic behaviors and those who avoid seeking help. The aims of the SHER 2 study are: a) determine the efficacy of an Internet-based emotion regulation intervention for sexual health and sexual satisfaction, and; b) explore the effects of the intervention on (1) emotion regulation skills; (2) mental health; (3) sexual self-perception.

Registry
clinicaltrials.gov
Start Date
May 5, 2021
End Date
July 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • between 18 and 65 years of age,
  • fluent in Brazilian Portuguese,
  • self-reported sexual problems, assessed in men by a score of \< 21 on the International Index Erectile Function (IIEF) and in women by a score of \< 26 on the Female Sexual Function Index (FSFI),
  • in a stable relationship for at least the preceding 3 months.

Exclusion Criteria

  • medical conditions that can interfere with the outcomes of the intervention, e.g., diabetes, cancer, cardiovascular problems,
  • ongoing psychotherapy.
  • no sexual activity in the previous 4 weeks.

Outcomes

Primary Outcomes

Change in Female Sexual Function Index (FSFI) at 6 months

Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)

this is a 19-item questionnaire for the assessment of sexual functioning in women in domains of sexual functioning (e.g., sexual arousal, orgasm, satisfaction, pain). Answers are provided using a 5-point Likert scale.

Change in International Index of Erectile Function (IIEF)at 6 months

Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)

The IIEF is 15-item, self-administered questionnaire for assessing sexual functioning in men. Answers are given on a 6-point Likert scale. The IIEF encompasses five different domains of sexual functioning: erectile function, orgasm function, sexual desire, intercourse satisfaction and overall satisfaction.

Change in Sexual Quotient (QS) at 6 months

Time Frame: baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up)

The QS is a brief and comprehensive tool composed of 10-questions, which are answered on a scale from 0 (never) to 5 (always). It addresses general sexual function, and stages of the sexual response cycle (desire, arousal, orgasm) and sexual satisfaction.

Secondary Outcomes

  • Sexual Modes Questionnaire (SMQ) - Automatic Thoughts subscale(baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up))
  • Sexual Self-Schema Scale (SSSS).(baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up))
  • Patient Health Questionnaire-9 (PHQ-9)(baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up))
  • General Anxiety Disorder - 7 (GAD-7)(baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up))
  • the Difficulties in Emotion Regulation Scale (DERS)(baseline, 2 months after baseline (end of intervention), 8 months after baseline (follow-up))

Study Sites (1)

Loading locations...

Similar Trials